A prospective randomised controlled trial of mycophenolate mofetil (MMF) as primary immunosuppression in paediatric liver transplant recipients - An interim analysis.

被引：0
|
作者：
Bansal, S [1 ]
Verma, A [1 ]
Taylor, R [1 ]
Cheeseman, P [1 ]
Samyn, M [1 ]
Heaton, N [1 ]
Rela, M [1 ]
Mieli-Vergani, G [1 ]
Dhawan, A [1 ]
机构：
[1] Inst Liver Serv, London, England
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：476A / 476A
页数：1
相关论文
共 50 条
  • [1] Prospective randomised controlled trial of mycophenolate mofetil as a primary immunosuppressant with tacrolimus in paediatric liver transplantation recipients.
    Bansal, Sanjay
    Verma, Anita
    Heaton, Nigel
    Rela, Mohammed
    Dhawan, Anil
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S178 - S179
  • [2] Mycophenolate mofetil (MMF) in pediatric liver transplant recipients
    Dhawan, A
    Lewis, PN
    Heaton, ND
    Baker, AJ
    Rela, M
    Hadzic, N
    Srinivasan, P
    MieliVergani, G
    [J]. HEPATOLOGY, 1997, 26 (04) : 1487 - 1487
  • [3] Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients
    Renz, JF
    Lightdale, J
    Mudge, C
    Bacchetti, P
    Watson, J
    Ascher, NL
    Emond, JC
    Rosenthal, P
    Roberts, JP
    [J]. LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (02): : 136 - 143
  • [4] A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients - An interim report
    Jain, AB
    Hamad, I
    Rakela, J
    Dodson, F
    Kramer, D
    Demetris, J
    McMichael, J
    Starzl, TE
    Fung, JJ
    [J]. TRANSPLANTATION, 1998, 66 (10) : 1395 - 1398
  • [5] A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C
    Jain, A
    Kashyap, R
    Demetris, AJ
    Eghstesad, B
    Pokharna, R
    Fung, JJ
    [J]. LIVER TRANSPLANTATION, 2002, 8 (01) : 40 - 46
  • [6] Pharmacokinetics of Mycophenolate Mofetil in Pediatric Liver Transplant Recipients to Optimize MMF Dose
    Barau, C.
    Habes, D.
    Debray, D.
    Taburet, A. M.
    Furlan, V.
    [J]. THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 651 - 652
  • [7] Steroid free tacrolimus and mycophenolate mofetil based immunosuppression in liver transplant recipients. Open label, randomised, prospective study.
    Studenik, P
    Mejzlik, V
    Stouracova, M
    Ondrasek, J
    Cerny, J
    [J]. LIVER TRANSPLANTATION, 2005, 11 (07) : C42 - C42
  • [8] Natural history of recurrence of hepatitis C (HEP CR) in liver transplant recipients (OLT) under mycophenolate mofetil (MMF) immunosuppression (IS).
    Fasola, CG
    Netto, GJ
    Christensen, LL
    Molmenti, EP
    Gonwa, TA
    Goldstein, RM
    Levy, MF
    Klintmalm, GB
    [J]. HEPATOLOGY, 2001, 34 (04) : 639A - 639A
  • [9] A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients
    Assy, N.
    Adams, P. C.
    Myers, P.
    Simon, V.
    Ghent, C. N.
    [J]. GUT, 2007, 56 (02) : 304 - 306
  • [10] Post-Transplant Anaemia in Paediatric Renal Allograft Recipients. A Comparison between Mycophenolate Mofetil (MMF) and Azathioprine (AZA) Based Immunosuppression
    Lamb, A.
    Boyle, J.
    Krischock, L.
    Ramage, I. J.
    [J]. PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1890 - 1891
12345